Nosocomial Bloodstream Infections Markedly Raise Death Rates

Between 2010 and 2020, nosocomial bloodstream infections led to a 3.4-fold increase in 90-day mortality at a hospital in Israel.

The last two decades have seen increased attention to the adverse outcomes associated with nosocomial infections as well as the advent of Centers for Medicare and Medicaid-mandated reporting of hospital-acquired central line–associated blood stream infections (CLABSIs), catheter-associated urinary tract infections, Clostridioides difficile infections, and certain surgical site infections. Now, investigators in Israel have assessed the clinical impact of hospital-associated bloodstream infections (HA-BSIs) in a retrospective propensity-matched cohort study of mortality and morbidity associated with these infections in adult patients at a single hospital from January 2010 through December 2020. In all, 1188 patients with bacterial HA-BSIs wer…

Reviewing Author

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

Nosocomial Bloodstream Infections Markedly Raise Death Rates

Topics

Reviewing Author